Search

Introduction Provisional prosthetic restorations play a crucial role in dentistry by protecting dentinal tubules, offering thermal insulation, and ensuring a precise fit during dental treatments. Computer-aided design and computer-aided manufacturing (CAD/CAM) have improved polymethyl methacrylate (PMMA), enhancing its mechanical properties such as hardness and resistance compared to traditional methods. However, bacterial accumulation remains a challenge due to inherent surface roughness. This study aims to assess and compare Streptococcus mutans adhesion on milled PMMA and conventional self-cure acrylic resin, providing insights into their microbial interaction dynamics. Materials and methods This study was a prospective trial approved by the Institutional Human Ethical Committee (SRB-IHEC) (registration number: IHEC/SDC/PROSTHO-2104/24/045) and registered in the Clinical Trial Registry, India (registration number: CTRI/2024/05/068196). The study involved 20 patients requiring single crowns in the right and left molar regions. Two groups were established: Group I (the milled PMMA group) and Group II (the conventional PMMA group). Criteria for participant selection and exclusion were set. A total of 120 swab samples from the buccal mucosa and tooth surfaces were collected before tooth preparation (the baseline) at one week and three weeks. Culture for S. mutans was done, and colony-forming units were counted. Data analysis was carried out using IBM SPSS Statistics for Windows, Version 26 (Released 2019; IBM Corp., Armonk, New York, United States). An independent sample t-test was employed to compare the two materials for crowns. To analyze changes over time within each group, a repeated-measures analysis of variance (ANOVA) was conducted. When the ANOVA test indicated significance, Tukey's post-hoc test was utilized for pairwise mean comparison. The level of significance was set at P < 0.05. Results The mean colony-forming units (CFU) counts for the milled PMMA group were 4.46 ± 0.167 CFU at baseline, 4.163 ± 0.058 CFU at one week, and 3.87 ± 0.19 CFU at three weeks. The mean CFU counts for the conventional PMMA group were 4.41 ± 0.13 CFU at baseline, 4.29 ± 0.114 CFU at one week, and 4.16 ± 0.108 CFU at three weeks. At baseline (before cementation), there was no difference between milled PMMA and conventional PMMA (P = 0.578). After one week, a significant difference between milled PMMA and conventional PMMA was observed (P < 0.005). After three weeks, a significant difference between milled PMMA and conventional PMMA persisted (P < 0.005).  Conclusion There was a significant reduction in microbial adhesion in both the milled and conventional PMMA groups. However, milled PMMA demonstrated a greater decrease in microbial adhesion as compared to conventional PMMA., Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Institutional Human Ethical Committee (SRB-IHEC) issued approval IHEC/SDC/PROSTHO-2104/24/045. The trial was registered in the Clinical Trial Registry, India (registration number CTRI/2024/05/068196), registration date: 31/05/2024. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Singh et al.)

Introduction Small compounds like L-leucine can boost bone regrowth by blocking certain effects, sparking cell reactions through signaling sequences. This research explored how combining L-leucine with hyaluronic acid on the developed novel graft material affects the bone's ability to conduct bone-building processes. Material and methods This study was designed as an in-vitro experiment, where a novel bone graft was formulated by integrating L-leucine with hyaluronic acid and incorporated into a hydroxyapatite-based ovine bone graft material. The sintering procedure was modified to include the amino acid L-arginine. Comprehensive examinations were executed using methodologies such as scanning electron microscopy, X-ray diffractometry, Fourier-transform infrared spectroscopy (FTIR), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and bone formation assay. These analyses were juxtaposed with the characteristics of the commercially accessible unaltered Bio-Oss, focusing on their physicochemical properties. The properties were compared with a commercially available bone graft material. Results The sintered hydroxyapatite/L-leucine graft displayed an interconnected pore structure, indicating that higher sintering and consolidation affected hydroxyapatite, as observed through scanning electron microscopy. X-ray diffraction (XRD) analysis confirmed hydroxyapatite in the sintered ovine bone samples, affirming their suitability for various biomedical applications. In the bone formation assay, optical density (OD) values were 61% for the hydroxyapatite/L-arginine graft, 58% for the Bio-Oss group, and 51% for the control group. The MTT assay, which assesses cell viability and metabolic activity, demonstrated biocompatibility and cell growth for all samples at 24 hours. Conclusion The research noted beneficial outcomes by incorporating L-leucine into the novel bone graft material with hyaluronic acid for bone grafting, demonstrating enhanced compatibility with existing bone tissue. However, the specific advantages of this combined approach are not fully known. It is essential to conduct more studies to uncover how this synergy works, assess its prolonged impacts, carry out clinical tests, and enhance the effectiveness of this blend for practical applications in bone graft surgeries., Competing Interests: Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: Scientific Review Board - (SRB/SDC/PROSTHO-20/22/TH-126) Samples were, however, obtained from the cortical hind limb femur goat bones collected from the local slaughterhouse located in Chennai, Tamil Nadu. Issued protocol number SRB/SDC/PROSTHO-20/22/TH-126. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Koppaka et al.)

Background Glass ionomer cement (GIC) serves as a crucial biomaterial in dental restoration, offering applications in filling, lining, and adhesive procedures. Nevertheless, its mechanical properties often fall short, particularly in regions subjected to considerable stress. To address this issue, zirconia nanoparticles are incorporated at specific levels. Aim To assess the antimicrobial efficacy and compressive resilience of GIC modified with zirconia nanoparticles synthesized through green synthesis methods. Material and methods Zirconia nanoparticles were synthesized via a green method utilizing aloe vera extract in solvent form. These nanoparticles were then mixed into GIC at different concentration levels. Group I incorporated zirconia nanoparticles at a concentration of 3%, Group II at 5%, and Group III at 10%, while Group IV was the control, consisting of traditional GIC. Following that, samples were prepared and underwent characterization through various analytical techniques. The ability to inhibit microbial growth and the compressive resilience of the groups were examined. Microbial inhibition against the bacterial strains was assessed through minimum inhibitory concentration (MIC), and the ability to withstand compression was gauged by measuring the maximum force the specimen could endure before fracturing. Data underwent analysis with Statistical Package for the Social Sciences (IBM SPSS Statistics for Windows, IBM Corp., Version 24.0, Armonk, NY). Repeated measures of analysis of variance (ANOVA) were utilized to gauge average MIC values and compressive strength. Following this, Tukey's post hoc test was employed for pairwise comparisons. Results The findings indicated, incorporating zirconia nanoparticles into GIC led to an improvement in its antimicrobial effectiveness, with a noticeable enhancement observed as the weight percent (% wt) of the additive increased. This improvement was notably noticeable in its effectiveness against Streptococcus mutans and Lactobacillus , exceeding that of the control with a noteworthy distinction. Furthermore, there were significant enhancements in compressive strength, in Group I (180.48 ± 1.02), Group II (191.25 ± 0.52), and Group III (197.52 ± 0.75), compared to Group IV (167.22 ± 1.235), with significant disparities (p < 0.05). Conclusion The research illustrates that introducing green-synthesized zirconia nanoparticles into GIC leads to heightened bactericidal potency and compressive resilience when contrasted with the control group (Group IV). Notably, the highest concentration of 10% demonstrated the most favourable antimicrobial attributes alongside enhanced strength. Consequently, integrating green-synthesized zirconia nanoparticles into GIC holds potential as a proficient material. In future studies, there should be an exploration of molecular chemistry and bonding mechanisms to enhance our comprehension of its capabilities., Competing Interests: Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Jain et al.)

Background Glass ionomer cement (GIC) plays a vital role in dental restorative procedures, serving purposes such as filling, luting, and adhesion. However, its inadequate mechanical properties pose challenges, especially in areas experiencing significant stress. To overcome this limitation, nanohydroxyapatite (nHA), known for its bioactive phosphate content, is added to the GIC at specific concentrations to improve its properties. Aim  We aim to evaluate the antimicrobial property and compressive strength of green-mediated nHA-incorporated GIC. Material and methods Green synthesis of hydroxyapatite nanoparticles was prepared using Moringa oleifera extract in a solvent form and eggshell waste served as the calcium source. These nHA powders were then integrated into the GIC at varying concentrations (3%, 5%, and 10%) designated as Group I, Group II, and Group III, respectively, while Group IV (control) consisted of conventional GIC. Specimens were fabricated and subjected to chemical structure analysis through Fourier transform infrared spectroscopy (FTIR), energy dispersive X-ray (EDX), and scanning electron microscopy (SEM). The antimicrobial activity and compressive strength of all groups were investigated. The antimicrobial activity against Streptococcus mutans and Lactobacillus was evaluated through the minimum inhibitory concentration (MIC) test, while compressive strength was evaluated by measuring the maximum force endured by the specimen before fracturing. Data analysis utilized IBM SPSS Statistics software, employing repeated measures ANOVA to determine mean MIC values and compressive strength, with Tukey's posthoc test for pairwise comparisons. Results The results of the study showed that the antimicrobial efficacy of nHA GIC improved with increasing weight percent (% wt) of the additive, exhibiting significantly enhanced activity against Streptococcus mutans and Lactobacillus compared to the control group (Group IV) with statistical significance (p < 0.05). Moreover, the compressive strength exhibited notable enhancements in the modified groups, including Group I (172.55 ± 0.76), Group II (178.16 ± 0.760), and Group III (182.45 ± 0.950), when compared to the control (162.46 ± 1.606), with statistically significant differences (p < 0.05). Conclusion The study demonstrates that the incorporation of green-mediated nHA-containing GIC results in superior antimicrobial efficacy and compressive strength compared to the control group (Group IV). In particular, the highest concentration of nHA-modified GIC (10%) exhibited the most favorable antimicrobial properties along with increased strength. Therefore, utilizing green-mediated nHA in the GIC shows promise as an effective restorative material. Future investigations should delve into the molecular chemistry and bonding mechanisms to further explore its potential., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Ilancheran et al.)

Background Glass ionomer cement (GIC) is widely recognized for its self-adhesive characteristics and biocompatibility, making it commonly used as a restorative material. However, challenges related to limited antibacterial effectiveness and relatively low mechanical properties have hindered its widespread clinical use. Clove and ginger are recognized for their potent antimicrobial activity against numerous pathogenic microorganisms. The present study aims to enhance the clinical applicability of GIC by modifying it with clove and ginger extract. Aim The objective of the study is to assess the antimicrobial effectiveness and compressive strength of GIC modified with ginger and clove extract. Materials and methods Ginger and clove extracts were prepared and incorporated into conventional GIC at three concentrations for each, creating ginger-modified GIC groups (Group A, Group B, and Group C) and clove-modified GIC groups (Group D, Group E, and Group F), with Group G as the control (conventional GIC without modification). The antimicrobial assessment was conducted on disc-shaped GIC specimens (3.0 mm height x 6.0 mm diameter) prepared using molds. Bacterial strains were used to evaluate antimicrobial properties, with minimum inhibitory concentration (MIC) assays conducted at intervals of one to four hours for both modified and unmodified groups. Compressive strength specimens were prepared using cylindrical molds (6.0 mm height × 4.0 mm diameter), according to the ISO (International Organization for Standardization) guidelines. The evaluation was conducted using a Zwick universal testing machine (ElectroPuls® E3000, Instron, Bangalore, India), with the highest force at the point of specimen fracture recorded to determine compressive strength. Statistical analysis was conducted utilizing a one-way analysis of variance (ANOVA) alongside Tukey's post hoc test, with a significance threshold set at p < 0.01. Results The antimicrobial effectiveness of clove and ginger-modified GIC was assessed through a MIC assay, revealing a statistically significant improvement in antimicrobial potency against Streptococcus mutans and Lactobacillus within the modified groups compared to the control group (p < 0.01). Increased extract concentration correlated with enhanced antimicrobial activity. Clove-modified GIC exhibited superior antimicrobial efficacy compared to ginger extract. Compressive strength was higher in clove-modified GIC groups (p < 0.01), with Group F showing a maximum value of 175.88 MPa, while other modified groups demonstrated similar results to the control, with a value of 166.81 MPa (p > 0.01). Conclusion The study concludes that both clove-modified GIC and ginger-modified GIC exhibited antimicrobial activity against Streptococcus mutans and Lactobacillus species. The antimicrobial activity was notably higher in clove-modified GIC compared to ginger-modified GIC. Additionally, the compressive strength of clove-modified GIC surpassed all other groups. Thus, clove-modified GIC emerges as a promising restorative material for addressing recurrent caries. Future investigation is necessary to assess the long-term durability of the material., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Paulraj et al.)

Background: Glass ionomer cements are commonly utilized in dental restorations due to their biocompatibility, strong chemical bond with dental tissues, and ability to resist tooth decay. However, their effectiveness can be compromised by the presence of persistent cavity-causing microorganisms. Therefore, it is essential to consider incorporating antibacterial agents into these restorative materials. Swertia chirayita (S. chirayita) and Terminalia arjuna (T. arjuna) are well-known for their rich composition of phytochemicals that can potentially inhibit the growth of bacteria. Hence, the current research is focused on modifying glass ionomer cement with Chirayita and T. arjuna extracts to enhance its antibacterial properties., Aim: This research aims to determine the antimicrobial efficacy and compressive strength of glass ionomer cement modified with Chirayita and T. arjuna extracts., Methodology: Plant extracts were prepared from both Chirayita and T. arjuna. The powder and liquid components of conventional glass ionomer cement (GIC) were mixed, followed by adding these extracts at three different concentrations. To assess antimicrobial properties, typical strains of Streptococcus mutans and Lactobacillus were employed to test both the modified GIC and unmodified GIC (used as a control). For Chirayita and T. arjuna-modified GIC, minimum inhibitory concentration (MIC) assays were conducted at three different concentrations. MIC was assessed at various time intervals ranging from 1 to 4 hours for modified and unmodified groups. Moreover, compressive strength was measured using cylindrical molds. The highest force exerted at the point of specimen fracture was recorded to calculate the compressive strength values in megapascal (MPa)., Results: The antimicrobial efficiency of Chirata and T. arjuna-modified GIC was evaluated using a MIC assay, indicating a statistically significant enhancement in antimicrobial potency against S. mutans and Lactobacillus within the modified groups in contrast to the control group (p<0.05). However, there were no notable changes in compressive strength when comparing the control group to the modified groups (p>0.05)., Conclusion: The antimicrobial effectiveness against S. mutans was observed to be greater in both T. arjuna and Chirayita-modified GIC. In the case of Lactobacillus, Chirayita-modified GIC exhibited more pronounced antimicrobial properties compared to T. arjuna. Importantly, both extracts did not alter the compressive strength of Conventional (unmodified) GIC. Hence, Chirayita-modified GIC appears to be a promising restorative material for combatting recurrent caries. Additional investigation is required to assess the material's stability over an extended period., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Devi et al.)

Background Photobiomodulation techniques, particularly low-level laser therapy (LLLT), have gained traction due to their ability to accelerate osseointegration by stimulating cellular metabolism and promoting tissue healing. This study explores the effectiveness of LLLT around dental implants at various intervals after placement. Using resonance frequency analysis (RFA), the implant stability quotient (ISQ) was measured to assess implant stability. Methodology This split-mouth, randomized, single-blinded clinical trial included 20 participants undergoing dental implant placement. The test group received LLLT while the control group had no laser treatment. Implant stability was assessed using RFA at one, two, four, and twelve weeks post-implant placement. Statistical analysis involved descriptive statistics, repeated-measures analysis of variance (ANOVA), and t-tests. Results The repeated-measures ANOVA analysis showed significant differences in the ISQ values between the LLLT group and the control group at two weeks and three months post-implant placement. The LLLT group exhibited higher ISQ values, indicating greater implant stability and improved osseointegration compared to the control group. These findings suggest the potential benefits of LLLT in enhancing dental implant outcomes. Conclusions LLLT shows promise in improving dental implant outcomes, with enhanced stability and osseointegration. Further research is needed to validate these results and integrate LLLT into routine dental implant procedures., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Shenoy et al.)